Evidence map›Paper›PMID 33036809›Full record

ArticleAnais brasileiros de dermatologia

Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Ediléia Bagatin, Caroline Sousa Costa, Marco Alexandre Dias da Rocha, Fabíola Rosa Picosse, Cristhine Souza Leão Kamamoto, Rodrigo Pirmez, Mayra Ianhez, Hélio Amante Miot

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Effects of isotretinoin on bone dynamics in the craniomaxillofacial region: a systematic review of preclinical evidence.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2026
    Pooled it
  2. Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Oral Isotretinoin and Its Uses in Dermatology: A Review.Drug design, development and therapy · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Ediléia BagatinDepartment of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Caroline Sousa CostaDermatology Discipline, Universidade Federal do Piauí, Piauí, PI, Brazil.
Marco Alexandre Dias da RochaDepartment of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Fabíola Rosa PicosseDepartment of Dermatology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Cristhine Souza Leão KamamotoPrivate Clinic, São Paulo, SP, Brazil.
Rodrigo PirmezCentro de Estudos dos Cabelos, Instituto de Dermatologia Professor Rubem David Azulay, Santa Casa da Misericórdia do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Mayra IanhezDepartment of Tropical Medicine and Dermatology, Universidade Federal de Goiás, Goiânia, GO, Brazil.
Hélio Amante MiotDepartment of Dermatology, Faculdade de Ciências Médicas e Biológicas de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil. Electronic address: heliomiot@gmail.com.
Universidade Federal de São Paulo · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal de Goiás · BRUniversidade Federal do Piauí · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIsotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescriptions require strict criteria.

objectiveTo communicate the experience and recommendation of Brazilian dermatologists on oral use of the drug in dermatology.

methodsEight experts from five universities were appointed by the Brazilian Society of Dermatology to develop a consensus on indications for this drug. Through the adapted DELPHI methodology, relevant elements were listed and an extensive analysis of the literature was carried out. The consensus was defined with the approval of at least 70% of the experts.

resultsWith 100% approval from the authors, there was no doubt about the efficacy of oral isotretinoin in the treatment of acne, including as an adjunct in the correction of scars. Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association; they are rare, individual, and should not contraindicate the use of the drug. Regarding unapproved indications, it may represent an option in cases of refractory rosacea, severe seborrheic dermatitis, stabilization of field cancerization with advanced photoaging and, although incipient, frontal fibrosing alopecia. For keratinization disorders, acitretin performs better. In the opinion of the authors, indications for purely esthetic purposes or oil control are not recommended, particularly for women of childbearing age.

conclusionsApproved and non-approved indications, efficacy and adverse effects of oral isotretinoin in dermatology were presented and critically evaluated.

Indexed as

Acne VulgarisDermatologic AgentsDermatologyAdministration, OralBrazilFemaleHumansIsotretinoinDermatologic AgentsIsotretinoinAcne vulgarisDermatitis, seborrheicIsotretinoinRosaceaVitamin A

Identifiers

PMID33036809
PMCPMC7772596
OpenAlexW3090215426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.